Compare SLDP & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLDP | INMD |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 848.8M | 861.7M |
| IPO Year | N/A | 2018 |
| Metric | SLDP | INMD |
|---|---|---|
| Price | $3.11 | $13.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $16.75 |
| AVG Volume (30 Days) | ★ 3.8M | 951.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.88 | $1.70 |
| Revenue Next Year | $10.00 | $3.99 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $13.16 |
| 52 Week High | $8.86 | $19.78 |
| Indicator | SLDP | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 30.58 | 34.62 |
| Support Level | $2.92 | N/A |
| Resistance Level | $4.70 | $14.80 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 3.29 | 1.93 |
Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.